Satiation

Abbot's Adds the Whole Burger to Their Product Line of High-Quality Plant-Rich Foods

Retrieved on: 
Wednesday, March 6, 2024
Sprouts, Satiation, Bleeding, Plant, The Fresh Market, Meat, Food, Health, Whole Foods Market, Vitamin Cottage Natural Grocers, Ground beef, Allergen, Taste, Fast food

COSTA MESA, Calif., March 6, 2024 /PRNewswire/ -- Abbot's—a wellness company crafting delicious and versatile plant-rich products from real, wholesome ingredients—is taking the next step in their mission to spread the power of real, good food with the Whole Burger.

Key Points: 
  • The Whole Burger is designed to honor both your cravings and your well-being.
  • The Whole Burger is crafted with mushrooms, aromatic herbs, and savory spices to give it a flavorful, tender bite.
  • Whole Foods Market is the first retailer to carry Abbot's Whole Burger, which is now available nationwide in select stores.
  • "We recognize a growing interest in wholesome options within the plant-based community," says Kara Maloney, Category Merchant at Whole Foods Market.

New Study Confirms Phenomix Sciences' Hungry Brain Test Identifies Abnormal Satiation and Predicts Response to Qsymia

Retrieved on: 
Wednesday, October 18, 2023
Patient, FDA, Physiology, Biomarker, Obesity, Weight loss, Physician, The Hungry Brain, Satiation, Phenotype, Research, Observation, Mayo Clinic, Machine learning, Gene, AI, Timothy, Medical imaging, Phentermine/topiramate

MENLO PARK, Calif., Oct. 18, 2023 /PRNewswire/ -- Results from a new obesity study conducted at Mayo Clinic to assess the utility of the Phenomix Sciences MyPhenome Hungry Brain test were presented at ObesityWeek 2023 by Mayo Clinic's Dr. Diego Anazco, M.D., research postdoctoral fellow in the lab of Dr. Andres Acosta, M.D., Ph.D. The study demonstrated that Phenomix's Hungry Brain biomarker test could predict both the Hungry Brain phenotype and identify high responders to phentermine-topiramate (phen-top, e.g., Qsymia), an FDA-approved anti-obesity medication for weight loss.

Key Points: 
  • The study demonstrated that Phenomix's Hungry Brain biomarker test could predict both the Hungry Brain phenotype and identify high responders to phentermine-topiramate (phen-top, e.g., Qsymia), an FDA-approved anti-obesity medication for weight loss.
  • The study used a cohort of data from a 12-month randomized control trial of patients on Qsymia to assess the MyPhenome Hungry Brain test.
  • the Hungry Brain phenotype), measured by calories to fullness, and the biomarker test identified patients who can achieve greater total body weight loss (TBWL) when treated with Qsymia.
  • Phenomix released its first two MyPhenome tests for Hungry Gut and Hungry Brain biomarkers this year.

Annals of Family Medicine: Papers examine diet and clinical strategies that could help alleviate obesity, hypertension and diabetes in the United States

Retrieved on: 
Tuesday, May 23, 2023
Family medicine, Obesity, Diet, MyPlate, Calorie, ANN, Social support, Weight loss, Quality of life, Diabetes, Research, VLC, Hypertension, DASH, Annals, Waist, Satiation, Patient, Cooking, Physician, Risk, Standard of care, Overweight, Prediabetes, Hunger, Dietary supplement

The first of these studies compares two diets commonly used by physicians to support weight loss in patients -- MyPlate and the Diabetes Prevention Program Calorie Counting Diet. Findings suggest that the MyPlate diet, the federally-approved successor to the food pyramid, may lead to greater feelings of satiety, facilitating weight loss among patients.

Key Points: 
  • However, effective, evidence-based interventions for weight loss are not commonly delivered in the primary care context.
  • New research in the May/June 2023 issue of the Annals of Family Medicine sheds light on how primary care providers can more effectively treat patients living with obesity.
  • The first of these studies compares two diets commonly used by physicians to support weight loss in patients -- MyPlate and the Diabetes Prevention Program Calorie Counting Diet.
  • Findings suggest that the MyPlate diet, the federally-approved successor to the food pyramid, may lead to greater feelings of satiety, facilitating weight loss among patients.

Global Membrane Market Report 2022: Sector is Expected to Reach $49.25 Billion by 2028 at a CAGR of 12.2% - ResearchAndMarkets.com

Retrieved on: 
Monday, April 17, 2023
Other Manufacturing, Manufacturing, NF, Food, Microplastics, Investment, Fever, Disruptor (video game), COVID, Noetics, USD, Reverse osmosis, Government, United States Environmental Protection Agency, RO, Membrane, EPA, Application, Water, Plant growth analysis, Material, Wastewater treatment, Bacteria, Rest, Satiation, Colloid, Sewage treatment, Ultrafiltration

The Global Membrane Market size was valued at USD 22.0 billion in 2021 and is expected to reach USD 49.25 billion by 2028, at a CAGR of 12.2% during the forecast period (2022-2028).

Key Points: 
  • The Global Membrane Market size was valued at USD 22.0 billion in 2021 and is expected to reach USD 49.25 billion by 2028, at a CAGR of 12.2% during the forecast period (2022-2028).
  • The market is anticipated to grow significantly as dairy processing and the food and beverage industries employ membrane technology.
  • The widespread adoption of membrane separation techniques is also projected to benefit from technological advancements that increase durability and reduce fouling possibilities.
  • The economic recovery and government initiatives to assist environmental protection are also predicted to be major drivers of the U.S. market for membrane separation technology.

True You Weight Loss Announces First Patient Enrolled in Ablate Weight Study Trial

Retrieved on: 
Tuesday, November 29, 2022
Cardiology, Managed Care, Diabetes, Health, General Health, Research, Hospitals, Surgery, Fitness & Nutrition, Science, Clinical Trials, Patient, Principal investigator, Endoscopy, Triangle, Weight loss, Brown University, Gastroenterology, Public health, ESG, University, Obesity medicine, Risk, Certification, Physician, Education, Thomas Jefferson University, Satiation, Anesthesia, Internal medicine, Bariatric surgery, RI, MD, Chapel Hill, Appetite, Ghrelin, Stomach, PLLC, American Board of Commissioners for Foreign Missions, American Board of Obesity Medicine, UNC Gillings School of Global Public Health, University of North Carolina at Pembroke, Obesity, Reiko True, Health insurance, Hospital, Science

True You Weight Loss has enrolled the first patient in the nation in a groundbreaking study to investigate the effects of gastric fundus ablation combined with Endoscopic Sleeve Gastroplasty (ESG) for the management of obesity.

Key Points: 
  • True You Weight Loss has enrolled the first patient in the nation in a groundbreaking study to investigate the effects of gastric fundus ablation combined with Endoscopic Sleeve Gastroplasty (ESG) for the management of obesity.
  • True You Weight Loss is still enrolling patients who live in the Triangle, N.C. region, and patients will be compensated for their time.
  • For more information about this and other active research studies at True You Weight Loss, please visit https://trueyouweightloss.com/research/ .
  • About True You Weight Loss, PLLC
    Founded by Dr. Christopher McGowan, True You Weight Loss, PLLC is the nations first dedicated endobariatric weight loss center.

EQS-News: The Best Thing Since Sliced Bread: This Agtech Company Brings On Its New Product For Health-Conscious Millennials

Retrieved on: 
Friday, October 28, 2022
Satiation, Food, Acquisition, Iron, NASDAQ, Starch, Digestion, IP, Temperature, Environment, Intellectual property, Germination, Agtech, Zinc, Magnesium, Climate change, Technology, Vitamin, Weight loss, AeroFarms, Mineral, Enzyme, Humidity, Agriculture, Grain boundary strengthening, Creativity, Advertising, Solution, Flour

The Best Thing Since Sliced Bread: This Agtech Company Brings On Its New Product For Health-Conscious Millennials

Key Points: 
  • The Best Thing Since Sliced Bread: This Agtech Company Brings On Its New Product For Health-Conscious Millennials
    In an age of widespread agricultural pollution and obesogenic foods, consumers are looking for sustainably farmed, healthy food options.
  • AgriFORCE Growing Systems (NASDAQ: AGRI) is launching its un(Think) Awakened Flour to meet the demands of this market.
  • AgriFORCE is an agtech company that is bringing solutions to the table through controlled-environment agriculture.
  • AgriFORCE plans to launch its new product , un(Think) Awakened Flour, soon to be available in stores by late 2022.

Celebrate Global Smoothie Day with Leading Wellness & Sustainability Company Shaklee

Retrieved on: 
Monday, October 3, 2022
Rhea, Harvard Business School, Midwest Universities Consortium for International Activities, Doctor of Philosophy, Hunger, Carbon, Yale Law School, FAAFP, Life, Vegetable, Yale College, CEO, Health, MD, Glycemic index, Multimedia, Milk, Diet, Yale University, World Economic Forum, Ice, Safety, Nutrient, Harvard University, Holiday, Mineral, Satiation, University council, Dietary supplement, Facebook, Instagram, Shaklee

This year, recognize this fun holiday by enjoying a refreshing smoothie with Shaklee , a leading wellness and sustainability company that developed the first plant-based protein supplement in the world.

Key Points: 
  • This year, recognize this fun holiday by enjoying a refreshing smoothie with Shaklee , a leading wellness and sustainability company that developed the first plant-based protein supplement in the world.
  • For more delicious smoothie recipes featuring Life Shake, visit: https://go.shaklee.com/naturally/recipes/life-shake-recipes/
    To learn more about Shaklee and become an ambassador, visit: www.shaklee.com .
  • Shaklee is a leading wellness company founded by Dr. Shaklee, who invented the first multivitamin in the US more than 100 years ago.
  • Roger Barnett is the Chairman and CEO of Shaklee Corporation, the first company in the world to be certified carbon neutral.